Entero Therapeutics Enters Material Definitive Agreement
Ticker: GRDX · Form: 8-K · Filed: Jul 16, 2025 · CIK: 1604191
| Field | Detail |
|---|---|
| Company | Entero Therapeutics, Inc. (GRDX) |
| Form Type | 8-K |
| Filed Date | Jul 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, company-name-change
TL;DR
Entero Therapeutics just signed a big deal, details TBD.
AI Summary
On July 15, 2025, Entero Therapeutics, Inc. entered into a material definitive agreement. The company, formerly known as First Wave BioPharma, Inc., is incorporated in Delaware and its fiscal year ends on December 31st. The filing does not contain specific financial figures or details about the agreement.
Why It Matters
This filing indicates a significant new contract or partnership for Entero Therapeutics, which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, but lacks specific details, creating uncertainty about its impact.
Key Players & Entities
- Entero Therapeutics, Inc. (company) — Registrant
- First Wave BioPharma, Inc. (company) — Former company name
- AzurRx BioPharma, Inc. (company) — Former company name
- BioPharma d'Azur, Inc. (company) — Former company name
- July 15, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Entero Therapeutics, Inc.?
The filing states that Entero Therapeutics, Inc. entered into a material definitive agreement on July 15, 2025, but does not provide specific details about the agreement's terms or purpose.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on July 15, 2025.
What were the previous names of Entero Therapeutics, Inc.?
Entero Therapeutics, Inc. was formerly known as First Wave BioPharma, Inc., AzurRx BioPharma, Inc., and BioPharma d'Azur, Inc.
In which state is Entero Therapeutics, Inc. incorporated?
Entero Therapeutics, Inc. is incorporated in Delaware.
What is the business address of Entero Therapeutics, Inc.?
The business address of Entero Therapeutics, Inc. is 777 Yamato Road, Suite 502, Boca Raton, FL 33431.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding Entero Therapeutics, Inc. (GRDX).